TAGRISSO 80 mg/1
osimertinib · TABLET, FILM COATED · AstraZeneca Pharmaceuticals LP
Tagrisso (osimertinib) is a prescription tablet taken by mouth that belongs to a class of drugs called kinase inhibitors, used to treat certain types of lung cancer. It works by targeting specific mutations in cancer cells to help slow or stop their growth.
Key Facts
- Brand Name
- TAGRISSO
- Generic Name
- osimertinib
- NDC Code (Product)
0310-1350- Manufacturer
- AstraZeneca Pharmaceuticals LP
- Strength
- 80 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA208065
- Drug Class
- Kinase Inhibitor [EPC]
- Marketing Start
- 11/13/2015
Recall History
No Recall HistoryFrequently Asked Questions
What is TAGRISSO used for?
Tagrisso (osimertinib) is a prescription tablet taken by mouth that belongs to a class of drugs called kinase inhibitors, used to treat certain types of lung cancer. It works by targeting specific mutations in cancer cells to help slow or stop their growth.
Is TAGRISSO a controlled substance?
TAGRISSO is not classified as a controlled substance by the DEA.
What is the generic name for TAGRISSO?
The generic name for TAGRISSO is osimertinib. There are no other listed brand versions of osimertinib.
What is the NDC code for TAGRISSO 80 mg/1?
The NDC (National Drug Code) for TAGRISSO 80 mg/1 is 0310-1350, listed by AstraZeneca Pharmaceuticals LP.
Other TAGRISSO Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)